$0.000001
At close: Jul 15, 3:08 PM EDT
Comments
Loading...
IR Biosciences Holdings Analyst Ratings and Price Targets | OTC:IRBS | Benzinga
IR Biosciences Holdings Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for IR Biosciences Holdings Corp from these most-recent analyst ratings.
Analyst Ratings for IR Biosciences Holdings
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for IR Biosciences Holdings (IRBS) stock?
There is no price target for IR Biosciences Holdings
What is the most recent analyst rating for IR Biosciences Holdings (IRBS)?
There is no analyst for IR Biosciences Holdings
When was the last upgrade for IR Biosciences Holdings (IRBS)?
There is no last upgrade for IR Biosciences Holdings
When was the last downgrade for IR Biosciences Holdings (IRBS)?
There is no last downgrade for IR Biosciences Holdings.
When is the next analyst rating going to be posted or updated for IR Biosciences Holdings (IRBS)?
There is no next analyst rating for IR Biosciences Holdings.
Is the Analyst Rating IR Biosciences Holdings (IRBS) correct?
There is no next analyst rating for IR Biosciences Holdings.
Browse analyst ratings and price targets on all stocks.
